Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
NA-704 by Biomed Industries for Amyotrophic Lateral Sclerosis: Likelihood of Approval
NA-704 is under clinical development by Biomed Industries and currently in Phase II for Amyotrophic Lateral Sclerosis. According to GlobalData,...
NA-831 by Biomed Industries for Major Depressive Disorder: Likelihood of Approval
NA-831 is under clinical development by Biomed Industries and currently in Phase II for Major Depressive Disorder. According to GlobalData,...
NA-941 by Biomed Industries for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
NA-941 is under clinical development by Biomed Industries and currently in Phase III for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to...
NA-921 by Biomed Industries for Fragile X Syndrome: Likelihood of Approval
NA-921 is under clinical development by Biomed Industries and currently in Phase III for Fragile X Syndrome. According to GlobalData,...
NA-921 by Biomed Industries for Rett Syndrome: Likelihood of Approval
NA-921 is under clinical development by Biomed Industries and currently in Phase III for Rett Syndrome. According to GlobalData, Phase...
NA-901 by Biomed Industries for Major Depressive Disorder: Likelihood of Approval
NA-901 is under clinical development by Biomed Industries and currently in Phase III for Major Depressive Disorder. According to GlobalData,...
NA-901 by Biomed Industries for Alzheimer's Disease: Likelihood of Approval
NA-901 is under clinical development by Biomed Industries and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...
NA-911 by Biomed Industries for Stroke: Likelihood of Approval
NA-911 is under clinical development by Biomed Industries and currently in Phase II for Stroke. According to GlobalData, Phase II...
NA-931 by Biomed Industries for Obesity: Likelihood of Approval
NA-931 is under clinical development by Biomed Industries and currently in Phase III for Obesity. According to GlobalData, Phase III...